CMD Bioscience LLC is a privately held company dedicated to the accurate prediction and characterization of therapeutically important protein-protein interactions and the discovery and early-stage validation of proteins, peptides and peptidomimetics for use in the pharmaceutical, biotech, and diagnostic industries.

The company has developed an empirical free energy function and complementary search algorithms that can be integrated to quantitatively and efficiently guide rational protein, peptide and peptidomimetic design.

In addition to our internal discovery programs, we offer a range of computational contract services and software licensing opportunities.

CMD Bioscience in the News
3/15/08 Press Release: Licensing Agreement with SUNY/Stony Brook
4/7/08 Article in the New Haven Register: "Unpredictable Proteins"